Search research articles
Contact Us
Filters
Showing results (51-60 of 97) with videos related to
Page
of 10
Sort By:
Proteomics
|
December 13, 2005
Inflammatory protein profile during systemic high dose interleukin-2 administration
Leonardo Rossi, Brian M Martin, Glen L Hortin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 17, 2016
Induction of Immune Response after Allogeneic Wilms' Tumor 1 Dendritic Cell Vaccination and Donor Lymphocyte Infusion in Patients with Hematologic Malignancies and Post-Transplantation Relapse
Nirali N Shah, David M Loeb, Hahn Khuu, et al.
Transfusion
|
September 12, 2018
Current practices for viability testing of cryopreserved cord blood products: an international survey by the cellular therapy team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative
Minoko Takanashi, Eileen Selogie, Jo-Anna Reems, et al.
Journal of Translational Medicine
|
September 8, 2017
Over-expression of BAG-1 in head and neck squamous cell carcinomas (HNSCC) is associated with cisplatin-resistance
Shutong Liu, Bo Ren, Hang Gao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 15, 2009
Serum vascular endothelial growth factor and fibronectin predict clinical response to high-dose interleukin-2 therapy
Marianna Sabatino, Seunghee Kim-Schulze, Monica C Panelli, et al.
Critical Care Medicine
|
April 9, 2005
Transfusion-related acute lung injury: definition and review
Pearl Toy, Mark A Popovsky, Edward Abraham, et al.
Cancer Letters
|
November 24, 2020
Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy
Diana Llopiz, Marta Ruiz, Leyre Silva, et al.
Bone Marrow Transplantation
|
September 9, 2024
Durable remission of refractory and advanced stage mycosis fungoides/sezary syndrome utilizing an "outpatient" alemtuzumab, fludarabine-based reduced intensity allogeneic hematopoietic cell transplantation
Phuong Vo, Ramaprasad Srinivasan, Enkhtsetseg Purev, et al.
Transfusion
|
June 20, 2008
Hematopoietic growth factors--use in normal blood and stem cell donors: clinical and ethical issues
Jeffrey McCullough, Jeffrey Kahn, John Adamson, et al.
Cytotherapy
|
January 19, 2010
Developments in clinical cell therapy
David Stroncek, Deborah Berlyne, Bernard Fox, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 97) with videos related to
Sort By:
Page
of 10
Proteomics
|
December 13, 2005
Inflammatory protein profile during systemic high dose interleukin-2 administration
Leonardo Rossi, Brian M Martin, Glen L Hortin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 17, 2016
Induction of Immune Response after Allogeneic Wilms' Tumor 1 Dendritic Cell Vaccination and Donor Lymphocyte Infusion in Patients with Hematologic Malignancies and Post-Transplantation Relapse
Nirali N Shah, David M Loeb, Hahn Khuu, et al.
Transfusion
|
September 12, 2018
Current practices for viability testing of cryopreserved cord blood products: an international survey by the cellular therapy team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative
Minoko Takanashi, Eileen Selogie, Jo-Anna Reems, et al.
Journal of Translational Medicine
|
September 8, 2017
Over-expression of BAG-1 in head and neck squamous cell carcinomas (HNSCC) is associated with cisplatin-resistance
Shutong Liu, Bo Ren, Hang Gao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 15, 2009
Serum vascular endothelial growth factor and fibronectin predict clinical response to high-dose interleukin-2 therapy
Marianna Sabatino, Seunghee Kim-Schulze, Monica C Panelli, et al.
Critical Care Medicine
|
April 9, 2005
Transfusion-related acute lung injury: definition and review
Pearl Toy, Mark A Popovsky, Edward Abraham, et al.
Cancer Letters
|
November 24, 2020
Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy
Diana Llopiz, Marta Ruiz, Leyre Silva, et al.
Bone Marrow Transplantation
|
September 9, 2024
Durable remission of refractory and advanced stage mycosis fungoides/sezary syndrome utilizing an "outpatient" alemtuzumab, fludarabine-based reduced intensity allogeneic hematopoietic cell transplantation
Phuong Vo, Ramaprasad Srinivasan, Enkhtsetseg Purev, et al.
Transfusion
|
June 20, 2008
Hematopoietic growth factors--use in normal blood and stem cell donors: clinical and ethical issues
Jeffrey McCullough, Jeffrey Kahn, John Adamson, et al.
Cytotherapy
|
January 19, 2010
Developments in clinical cell therapy
David Stroncek, Deborah Berlyne, Bernard Fox, et al.
Page
of 10